奥沙利铂
吉西他滨
福克斯
医学
顺铂
胆道癌
化疗
内科学
氟尿嘧啶
结直肠癌
肿瘤科
卡培他滨
癌症
胃肠病学
梅德林
胆道
普通外科
胆囊癌
标识
DOI:10.1016/s1470-2045(21)00543-x
摘要
The prognosis of patients with advanced biliary tract cancer is poor. Preferred first-line chemotherapy for these patients is a combination of gemcitabine plus cisplatin, following the results of the ABC-02 trial.1 The ABC-06 trial2 compared active symptom control with active symptom control and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) in patients with advanced biliary tract cancer who had progressed on gemcitabine plus cisplatin, and showed improved overall survival with the addition of FOLFOX.
科研通智能强力驱动
Strongly Powered by AbleSci AI